UiPath is rated a buy at $12, trading at 15x FY2027 and 13x FY2028 earnings, with strong 80%+ gross margins. Revenue grew 17% to $418M in Q1 FY2027, ARR rose 12% to $1.9B, and non-GAAP operating margin reached 22%. Agentic automation (Maestro) is UiPath's key catalyst, but AI monetization is unproven; net retention at 109% needs to improve for higher growth.
PATH's six-month pullback comes as AI adoption, enterprise customer growth and profitability improve, creating a more attractive entry point.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
In the closing of the recent trading day, UiPath (PATH) stood at $11.68, denoting a -1.02% move from the preceding trading day.
PATH's pullback has lowered its valuation as improving profitability, ARR growth and an upbeat outlook strengthen the long-term investment case.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PATH's Maestro Case launch expands its reach into complex enterprise workflows, deepening its push beyond traditional automation.
PATH's AI orchestration push and growing enterprise adoption make it a more compelling buy over NU despite Nubank's strong fintech growth.
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PATH is seeing agentic AI move from pilot projects to production deployments, strengthening demand for its automation platform.